Aurora, Colorado 80045


Purpose:

All healthcare providers strive continually to improve the outcome of their treatment approaches. The investigators hypothesize that preventive analgesics administered before a child is sedated with a Demerol-Vistaril regimen will improve the outcome of a sedation.


Study summary:

To increase outcomes for patients receiving dental sedation by providing significant evidence that the new regimen improves the quality of sedation and results in an improved post sedation ability to eat, drink, resume normal activities and require less additional pain medications.


Criteria:

Inclusion Criteria: - We intend to enroll 300 children between the ages of 2 - 8 years of all ethnicities for this prospective, placebo controlled, randomized, and double-blind trial. All children that fulfill our general selection criteria for this sedation regimen will be eligible for this study. Exclusion Criteria: - Children who do not meet our general selection criteria for this sedation regimen will be ineligible for this study.


NCT ID:

NCT01971853


Primary Contact:

Study Director
Jeffrey O Young, DDS
University of Colorado, Denver

Jeffrey O Young, DDS
Phone: 720-777-8895
Email: jeffrey.young@childrenscolorado.org


Backup Contact:

Email: ulrich.klein@childrenscolorado.org
Ulrich Klein, DDS
Phone: 720-777-2791


Location Contact:

Aurora, Colorado 80045
United States

Jeffrey O Young, DDS
Phone: 720-777-8895
Email: jeffrey.young@childrenscolorado.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 24, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.